Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04687020
Recruitment Status : Enrolling by invitation
First Posted : December 29, 2020
Last Update Posted : November 22, 2021
Sponsor:
Information provided by (Responsible Party):
NS Pharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : November 2031
Estimated Study Completion Date : November 2031